Methods: In order to determine the contribution of IL-1Ra-deficient (Ra-/-) and wild-type (WT) BM cells to neointimal formation, we developed four types of BM chimeric mice (BMT WT → WT (n = 12), BMT Ra-/-→ WT (n = 12), BMT WT → Ra-/-(n = 12) and BMT Ra-/-→ Ra-/-(n = 12)). At four weeks after BMT, we induced vascular injury by placing a non-occlusive cuff around the femoral artery. Histological analyses were subsequently performed two weeks after injury. Results: Neointimal formation was decreased in the BMT WT → Ra-/mice compared with that observed in the BMT Ra-/-→ Ra-/mice (p＜0.001), but significantly more so in the BMT Ra-/-→ WT (p＜0.01) and BMT WT → WT (p＜0.01) mice. In contrast, the neointimal formation in the BMT Ra-/-→ WT mice was significantly increased compared with that noted in the BMT WT → WT mice (p＜0.05). In addition, immunostaining revealed that Mac3-positive areas were significantly increased in the BMT Ra-/-→ Ra-/mice compared with those seen in the other three groups (p＜0.001), with a significantly decreased percentage of alpha-SMA-positive areas in the neointima in the BMT Ra-/-→ Ra-/mice compared with that found in the remaining groups (p＜0.001). Furthermore, IL-1Ra staining demonstrated the IL-1Ra expression in several inflammatory cells in the adventitia in the BMT WT → WT and BMT WT → Ra-/mice, compared to the neointima in the BMT WT → WT and BMT Ra-/-→ WT mice.
Introduction
Neointimal formation after vascular injury is characterized by the activation, migration and proliferation of vascular smooth muscle cells (VSMCs) and is associated with inflammatory mediators, such as IL-1Ra in the development of neointimal formation after injury, BMT was performed as previously described 9) . For BMT, BMCs were obtained from IL-1Ra-/-and wild-type mice (5 to 6 weeks of age) and purified BMCs (10 7 cells/mouse) were transplanted intravenously into lethally irradiated (750 rad) recipient IL-1Ra-/-mice (IL-1Ra-/-to IL-1Ra-/-(BMT Ra-/-→ Ra-/-) mice and WT to IL-1Ra-/-(BMT WT → Ra-/-) mice) or WT mice (IL-1Ra-/-to WT (BMT Ra-/-→ WT ) mice and WT to WT (BMT WT → WT ) mice) at 6 weeks of age.
Vascular Injury
Vascular injury was induced at four weeks after BMT. The mice were anesthetized with the intraperitoneal injection of pentobarbital (dose: 50 mg/kg bodyweight), and an additional dose was provided if the mouse moved in pain during surgery. Therefore, no movements indicating pain were detected, and the heart and respiratory rates remained stable during the procedure. The right femoral artery was dissected from its surroundings, and vascular injury was induced by placing a non-occlusive cuff (length: 2 mm; internal diameter: 0.56 mm; Becton Dickinson) around the femoral artery, as previously described 6, 10) .
Blood Pressure Measurement
Systolic blood pressure was measured according to the tail-cuff method (MK-2000; Muromachi Kikai, Tokyo) without anesthesia.
Plasma Lipid Measurement
After fasting the mice for seven hours, the plasma total cholesterol levels were measured using an enzymatic assay, as previously described by Hedrick et al. 11) .
Tissue Preparation and Histology
After measuring the tail-cuff systolic blood pressure, the animals were euthanized via pentobarbital injection (dose: 100 mg/kg bodyweight) and perfused with 0.9% NaCl, followed by 4% paraformaldehyde. The femoral artery was then harvested, fixed overnight in 4% paraformaldehyde, embedded in OCT compound (Tissue-Tek; Sakura Finetechnical Co, Tokyo, Japan) and sectioned (8 μm in thickness). All samples were routinely stained with Victoria blue hematoxylineosin, followed by antigen-specific immunohistochemistry. SMCs were visualized with α-SMA staining (Roche), endothelial cells were visualized with CD31 staining (BD Biosciences), and mouse macrophages were visualized with monoclonal Mac3 staining (BD Biosciences). The expression of IL-1Ra was cytokines. IL-1β, a chemoattractant and mitogen for VSMCs 1) , is overexpressed at sites of active proliferation and migration subsequent to injury 2) . Furthermore, an earlier study reported that IL-1 type 1 receptor gene-deficient mice develop less neointimal tissue than wild-type (WT) mice 3) . Taken together, these findings suggest that IL-1 promotes neointimal formation.
The IL-1 receptor antagonist (IL-1Ra) negatively regulates IL-1 signaling by binding and blocking the functional receptor without activating it 4) . Therefore, IL-1Ra plays an anti-inflammatory role in the development of acute and chronic inflammation 5) . We previously demonstrated the expression of IL-1Ra on bone marrow (BM)-derived cells as well as endothelial cells in injured arteries in WT mice 6) . We also showed that IL-1Ra-deficient (IL-1Ra-/-) mice exhibit postinjury neointimal formation 6) , thus suggesting that IL-1Ra plays an important role in suppressing neointimal formation in vivo. However, the importance of various cell types as sources of IL-1Ra for neointimal formation remains elusive, although a recent study demonstrated that IL-1β signaling plays an important role in promoting neointimal formation after arterial ligation in mice and that both circulating and arterial wall cells are involved in this process 7) .
Aim of the Study
In the present study, we used BM cell (BMC) transplantation (BMT) to definitively test the hypothesis that IL-1Ra originating from both BM-derived cells and non-BM intrinsic cells helps to suppress inflammation and neointimal formation after injury.
Methods

Animals
The process used to generate IL-1Ra-/-mice used in this study has been described previously 6, 8) . The mice lacked all four isoforms of IL-1Ra and were backcrossed to the C57BL/6J strain for more than eight generations. In this study, we used only male mice in order to rule out gender differences. The mice were fed a normal chow diet. The experimental protocol conformed to the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by both the National on the lower side of the membrane were collected. The cells were then lysed and detected using the patented CyQuant GR dye.
Enzyme-Linked Immunosorbent Assay
The serum levels of IL-1Ra were determined according to an enzyme-linked immunosorbent assay, as previously described 12) .
Statistical Analysis
The results are presented as the mean±SEM. The two groups were compared using Student's t -test or the Student-Newman-Keuls test with a one-way analysis of variance. A p value of ＜0.05 was considered to indicate a significant difference.
Results
Phenotypic Characteristics
Four weeks after BMT, we observed no significant differences in body weight (BMT Ra-/-→ Ra-/mice: 24.5±0.8, BMT WT → Ra-/mice: 25.5±0.7, BMT Ra-/-→ WT mice: 25.3±0.6, BMT WT → WT mice: 26.1±0.6 g), systolic blood pressure (90±9, 97±5, 100±4 or 96±8 mmHg) or total cholesterol levels (101±4, 95±3, 98±3 or 102±4 mg/dL) among the four groups (n = 6 per group).
Neointimal Formation After Cuff Injury
In order to assess whether IL-1Ra originating from BM cells and/or non-BM intrinsic arterial cells mediates neointimal formation, we investigated the effects of cuff-induced injury on the femoral arteries in the four types of BMT mice: BMT Ra-/-→ Ra-/-, BMT WT → Ra-/-, BMT Ra-/-→ WT and BMT WT → WT (n = 12 per group). Fig. 1 shows representative cross-sections of femoral arteries harvested two weeks after injury. A morphometric analysis revealed that both the amount of neointimal formation and the intimal/media ratio were significantly decreased in the BMT WT → Ra-/mice compared with those observed in the BMT Ra-/-→ Ra-/mice (p＜0.001) and significantly more so compared with those observed in the BMT Ra-/-→ WT (p＜0.01) and BMT WT → WT mice (p＜0.01). (Fig. 1) .
Detection of Endothelial Cells, Macrophages and Smooth Muscle Cells
As a previous study reported that early re-endothelialization following vascular injury inhibits neointimal formation 13) , we performed immunostaining for the endothelial marker CD31. Consequently, the CD31-positive areas in the injured BMT Ra-/-→ Ra-/arteries (n = 12) were significantly decreased compared also assessed (Santa Cruz Biotechnology).
Morphometry
We used 10 equally spaced (200-μm interval) cross-sections to quantify the area of the neointimal lesions in each mouse. The areas of the intima, media and regions positive for immunostaining were measured using NIS-Elements (Nikon).
Macrophage Preparation
Peritoneal macrophages were recovered from the mice four days after the intraperitoneal injection of 2 mL of 2% thioglycollate broth (Nissui Pharmaceutical Co., Tokyo, Japan).
Quantitative Real-Time PCR
RNA was prepared from the peritoneal macrophages using TRI Reagent (Sigma-Aldrich). Complementary DNA (cDNA) was synthesized using reverse transcriptase from 200 ng of total RNA according to the manufacturer's protocol (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems). The following oligonucleotide primer pairs were used: IL-1β sense, 5'-TGG TGT GTG ACG TTC CCA TT-3'; antisense, 5'-CAG CAC GAG GCT TTT TTG TTG-3'; TNF-α sense, 5'-TCC CAG GTT CTC TTC AAG GGA-3'; antisense, 5'-GGT GAG GAG CAC GTA GTC GG -3'; CCR2 sense, 5'-GGG TCA TGA TCC CTA TGT GG-3'; antisense, 5'-TCC ATG AGC AGT GGT TTG AA-3'; 18S rRNA sense, 5'-AGT CGG AGG TTC GAA GAC GAT-3'; antisense, 5'-GCG GGT CAT GGG AAT AAC G -3'. The primers were mixed with the THUNDERBIRD SYBR qPCR Mix (TOYOBO). The ABI PRISM 7900HT machine (Applied Biosystems) was used for real-time PCR with denaturation at 95 ℃ for 10 minutes, followed by 40 amplification cycles (15 seconds at 95 ℃ and 30 seconds at 60 ℃). Each mRNA expression level was corrected according to the 18S mRNA level. The data were analyzed using the RQ Manager 1.2 software program (Applied Biosystems).
In Vitro Migration Assay
The degree of migration of the mouse peritoneal macrophages was measured in a modified Boyden migration assay chamber using the Chemicon QCM 96-well (5-μm) Cell Migration Assay kit (Millipore). A total of 1 X 10 5 cells obtained from BMT Ra-/-→ Ra-/or BMT WT → Ra-/mice were loaded into the migration chamber, and medium containing 10 ng/mL of MCP-1 was placed in the lower chamber. After allowing cell migration for 12 hours, the cells were removed from the upper side of the membrane, and migratory cells Advance Publication Journal of Atherosclerosis and Thrombosis Accepted for publication: June 5, 2014 Published online: September 16, 2014 positive areas in the neointima in the BMT Ra-/-→ Ra-/mice (n = 12) were significantly increased compared with those seen in the other groups (n = 12 per group) (p＜0.001) ( Fig. 3) , thus suggesting that IL-1Ra-deficient macrophages migrate more actively into injured arteries than WT macrophages in BMT Ra-/-→ Ra-/mice. In contrast, the percentage of α-SMA-positive areas in the neointima in the BMT Ra-/-→ Ra-/mice (n = 12) was more significantly decreased than that noted in the other groups (n = 12 per group) (p＜0.001) ( Fig. 4) , although the total number of α-SMA-positive area in the BMT Ra-/-→ Ra-/mice was increased most significantly among the four groups, as in our previous report 6) . These results suggest that IL-1Ra originating from both BM-derived cells and non-BM intrinsic arterial cells reduces inflammation in injured arteries and increases the percentage of α-SMA-positive areas in the neointima.
Macrophage Functional Assay In Vitro
Because the Mac3-positive areas in the neointima with those observed in the other groups (n = 12 per group) (p＜0.001) ( Fig. 2) , suggesting that IL-1Ra originating from BM-derived cells and non-BM intrinsic arterial cells protects endothelial cells from injury. In addition, we performed immunostaining of macrophages (Mac3) and VSMCs (α-SMA). Although numerous macrophages were noted between the cuff and artery, a significant number of cells was dropped during sectioning, thus preventing us from obtaining an accurate count in these areas. We subsequently counted macrophages in the adventitia within a 50-μm radius from the external elastic lamina, which was included in almost all of the histological samples. The number of Mac3-positive cells in that area was significantly increased in the BMT Ra-/-→ Ra-/mice (n = 12) compared with that observed in the other groups (n = 12 per group) (p＜0.001); however, there were no significant differences in this parameter among the remaining three groups (BMT Ra-/-→ Ra-/mice: 280±33, BMT WT → Ra-/mice: 64±5, BMT Ra-/-→ WT mice: 73±10, BMT WT → WT mice: 54±7 cells). Furthermore, the Mac3- Therefore, in order to examine the functional implications of the higher CCR2 expression observed in the macrophages obtained from the BMT Ra-/-→ Ra-/mice versus the BMT WT → Ra-/mice, further experiments were conducted to determine the chemotactic responses of the macrophages to MCP-1, a specific CCR2 ligand, in both groups. The migration activity of the macrophages obtained from the BMT Ra-/-→ Ra-/mice (n = 6) was 4.6-fold higher than that of the macrophages obtained from the BMT WT → Ra-/mice (n = 6) (p＜0.01) (Fig. 5B) . These results suggest that the increased presence of inflammatory cells in the neointima in the BMT Ra-/-→ Ra-/mice resulted from an increased recruitment of inflammatory cells.
IL-1Ra Proteins in the Injured Arteries and Serum
Immunostaining for IL-1Ra revealed that several (but not all) inflammatory cells in the adventitia expressed IL-1Ra in both the BMT WT → WT and BMT WT → Ra-/mice, but not the BMT Ra-/-→ WT or BMT Ra-/-→ Ra-/mice (Fig. 6A) . In contrast, we detected IL-1Ra proteins in the neointima and SMCs in the of BMT WT → Ra-/mice were significantly decreased compared with those observed in the BMT Ra-/-→ Ra-/mice, we hypothesized that IL-1Ra potentially alters the macrophage function. In order to investigate the effects of IL-1Ra on the macrophage function, we assessed the mRNA expression levels of IL-1β, TNF-α and CCR2 in peritoneal macrophages obtained from the BMT Ra-/-→ Ra-/and BMT WT → Ra-/mice. mRNA was extracted from thioglycollate-elicited peritoneal macrophages in both mice. Regarding proinflammatory cytokines, the results of real-time PCR revealed that the mRNA levels of both IL-1β (2.8-fold, p＜0.01) and TNF-α (12.1-fold, p＜0.01) were significantly higher in the BMT Ra-/-→ Ra-/mice than in the BMT WT → Ra-/mice (Fig. 5A) . Furthermore, the levels of CCR2 mRNA in the BMT Ra-/-→ Ra-/mice were significantly increased by 4.9-fold compared with those noted in the BMT WT → Ra-/mice (p＜0.001) (Fig. 5A) . These observations suggest excessive activation of the macrophages obtained from the BMT Ra-/-→ Ra-/mice compared with that observed in the BMT WT → Ra-/mice, even at the same level of stimulation. of vascular injury 6) . Furthermore, a recent report demonstrated that BMCs contribute to post-injury neointimal formation 14) . However, the precise roles of IL-1Ra derived from various cell types in neointimal formation remain unclear. The present study is the first to demonstrate the critical role of IL-1Ra originating from both BM-derived cells and non-BM intrinsic arterial cells in the process of neointimal formation after injury.
In this study, several mechanisms demonstrated that IL-1Ra originating from both BM-derived cell and non-BM intrinsic arterial cells reduces post-injury neointimal formation in IL-1Ra-/-mice. First, WT macrophages reduced inflammation and migration into the injured arteries in the IL-1Ra-/-mice. Indeed, the Mac3-positive areas in the neointima in the BMT Ra-/-→ Ra-/mice were significantly increased compared with those observed in the BMT WT → Ra-/mice, suggesting that IL-1Ra-deficient macrophages migrate more actively into injured arteries than WT macro-media in both the BMT WT → WT and BMT Ra-/-→ WT mice, but not in the BMT WT → Ra-/or BMT Ra-/-→ Ra-/mice (Fig. 6A) . These findings suggest that the inflammatory cells were derived from BM cells, whereas the neointima was derived from non-BM intrinsic arterial cells in the injured arteries.
As expected, we found no IL-1Ra proteins in the serum in the BMT Ra-/-→ Ra-/mice, and the serum IL-1Ra levels in the BMT WT → WT mice were the highest among all four groups (Fig. 6B) . Interestingly, the serum levels of IL-1Ra in the BMT Ra-/-→ WT mice were significantly higher than those observed in the BMT WT → Ra-/mice (Fig. 6B) . These results suggest that non-BM cells function as the main source of serum IL-1Ra proteins.
Discussion
An earlier study showed that the IL-1Ra expression increases in injured arteries during the early phase capability of adventitial cells to migrate through the media and into the intima has been obtained by transplanting cells onto the adventitial side of arteries and monitoring the movement of the cells after arterial injury 18, 19) . These findings suggest that cells originating in the adventitia migrate to the neointima, where they contribute to post-injury intimal hypertrophy. Previous studies have also demonstrated that the inhibition of early adventitial inflammation decreases injury-induced neointimal formation 15, 20) . In the present study, BMCs obtained from WT mice induced the expression of IL-1Ra in inflammatory cells in the adventitia in the IL-1Ra-/-mice, while IL-1Ra derived from inflammatory cells suppressed adventitial inflammation in an autocrine manner, resulting in the reduction of neointimal formation. Third, we detected serum IL-1Ra proteins in the BMT WT → Ra-/mice, and the serum IL-1Ra protein levels in the BMT Ra-/-→ WT mice were found to be significantly decreased compared with those observed in the BMT WT → WT mice. Serum IL-1Ra likely plays a useful role in the suppression of post-injury neointimal formation. Interest-phages. Furthermore, our in vitro study demonstrated that the MCP-1-mediated migration activity of the macrophages obtained from the BMT Ra-/-→ Ra-/mice was 4.6-fold higher than that of the macrophages obtained from the BMT WT → Ra-/mice. Furthermore, real-time PCR revealed that the mRNA levels of both IL-1β and TNF-α were significantly higher in the BMT Ra-/-→ Ra-/mice than in the BMT WT → Ra-/mice. These findings suggest that WT macrophages decrease migration and the production of proinflammatory cytokines in injured arteries, thus reducing neointimal formation. Second, the WT BMC-derived inflammatory cells around the injured arteries expressed IL-1Ra proteins in both the BMT WT → WT and BMT WT → Ra-/mice. An early event observed following many forms of arterial injury is adventitial inflammation with the accumulation of monocytes and activated macrophages in the adventitia 15, 16) . Adventitial cells initially respond to injury with increased cell proliferation and then later appear to migrate out of the adventitia, subsequently making a significant contribution to neointimal lesion formation 17, 18) . Direct evidence for the the neointima in the injured arteries was derived from non-BM intrinsic arterial cells rather than BM-derived cells. A previous study identified only a few BMderived cells in the neointima after cuff injury 14) , potentially supporting our results. Therefore, the IL-1Ra expression in the neointima may suppress inflammation and protect the migration of inflammatory cells into the neointima, thus resulting in decreased neointimal formation after injury. Our findings have several clinical implications. For example, previous reports have documented an ingly, an earlier study in a porcine model demonstrated that the administration of IL-1Ra following coronary artery injury and stenting inhibits neointimal formation 21) . Taken together, vascular injury induces WT BMC-derived cells (e.g., monocytes and macrophages) to migrate to the site of injury in arteries. Accumulated WT BMC-derived cells then secrete IL-1Ra, which decreases inflammation and reduces the migration of inflammatory cells into the injured area. Furthermore, the IL-1Ra secreted in BMT WT → Ra-/mice inhibits inflammation and reduces the migration and proliferation of VSMCs, resulting in decreased neointimal formation after injury.
As an earlier study reported that early re-endothelialization following vascular injury inhibits neointimal formation 13) , we used CD31 immunostaining to examine post-injury re-endothelialization. Consequently, the CD31-positive areas in the injured arteries in the BMT Ra-/-→ Ra-/mice were found to be significantly decreased compared with those observed in the other mice (p＜0.001). We propose the following biological mechanisms to account for these results. First, because the neointima in the BMT Ra-/-→ Ra-/mice contained more Mac3-positive cells than those observed in the other mice, active inflammation induced by IL-1Ra-deficient inflammatory cells may continue to injure endothelial cells and impair re-endothelialization in injured arteries. Several studies have shown that macrophages induce endothelial cell apoptosis [22] [23] [24] , and TNF-α stimulates this process 25) via the activation of caspase-3 26) . Our in vitro study also demonstrated that the mRNA levels of TNF-α were significantly higher in the BMT Ra-/-→ Ra-/mice than in the BMT WT → Ra-/mice. These findings support our speculation that endothelial cell injury is induced by IL-1Ra-deficient inflammatory cells. Second, as a previous in vitro study demonstrated that the IL-1Ra expression increases endothelial proliferation 27) , our results suggest that BMC-derived IL-1Ra directly promotes re-endothelialization. Taken together, BMCderived IL-1Ra may protect endothelial cells against inflammation while also increasing their proliferation, thereby promoting re-endothelialization.
Regarding the role of IL-1Ra in non-BM cells, our data showed that non-BM cell-derived IL-1Ra also suppresses arterial inflammation. First, the serum levels of IL-1Ra in the BMT Ra-/-→ WT mice were significantly higher than those observed in the BMT WT → Ra-/mice, suggesting that non-BM cells function as the main source of serum IL-1Ra proteins. Second, we detected IL-1Ra proteins in the neointima in both the BMT WT → WT and BMT Ra-/-→ WT mice, but not the BMT WT → Ra-/or BMT Ra-/-→ Ra-/mice, indicating that The IL-1 signaling pathway has been reported to be associated with the development of atherosclerotic plaque and acute coronary syndrome (ACS) 30, 31) . A recent animal study reported that IL-1Ra-/-mice display significantly larger infarcts and more severe heart dysfunction after experimental acute myocardial infarction (AMI) than corresponding WT mice 32) . Furthermore, a large secondary prevention trial investigating the efficacy of an IL-1 blocker in patients with prior AMI is currently ongoing 33, 34) . If the trial identifies a novel cytokine-based therapy for the secondary prevention of AMI, BMT therapy may prove to be an effective alternative or additional treatment for this condition. However, when administering BMT therapy in ACS or MI patients, physicians should consider the type of donor. Recent studies have demonstrated that the donor AMI activates the IL-1 autosomal recessive autoinflammatory syndrome, deficiency of the interleukin-1 receptor antagonist (DIRA), the onset of which occurs around birth, with life-threatening systemic inflammation 28, 29) . Children with DIRA are effectively treated with anakinra, a biologic agent and recombinant form of IL-1Ra. However, in one study, a trial of anakinra discontinuation led to relapse within 36 hours 28) . Treatment with anakinra should therefore be lifelong. In the present study, BMCs derived from WT mice reduced inflammation and increased the serum levels of IL-1Ra in the IL-1Ra-/-mice, suggesting that BMT therapy for DIRA may reduce inflammation, thus reducing the frequency of anakinra injection and the consequent risk of infection and adverse side effects. However, determining whether BMT is an effective therapy for patients with DIRA will require further study. signaling pathway and alters the composition of BMCs, thus resulting in reduced therapeutic potential for survival as well as cardiac remodeling after MI 35, 36) . These findings suggest that the suppressive effects of BM-derived cells on the IL-1 pathway play a central role in improving both the vascular and cardiac function in these patients. Our results partially support this hypothesis.
Conclusion
In conclusion, the IL-1Ra present in both BMderived cells and non-BM cells helps to suppress arterial inflammation and promote re-endothelialization, thus resulting in decreased neointimal formation after arterial injury. These novel findings shed new light on the mechanisms underlying the development of atherosclerosis and restenosis after angioplasty.
